SBMFF - Week In Review: China Life Science Posts $1.3 Billion In Deals

• Pacific Biosciences, a San Francisco Bay area company offering long-read sequencing platforms, will acquire Omniome, a San Diego short-read company, for up to $800 million.
• Shanghai's Zai Lab and Schrödinger of New York formed a global collaboration to develop a novel oncology product targeting DNA damage. Once a candidate is identified, Zai will assume responsibility for development, manufacturing and commercialization.
• Akeso and Sino Bio were approved to launch their partnered anti-PD-1 injection in China for classic Hodgkin's lymphoma.

For further details see: